Skip to main content

Want a detailed portfolio tracker?

Palatin Technologies (PTN) P/E (2025 - 2026)

Palatin Technologies (PTN) P/E from Nov 12, 2025 to Jul 21, 2026. The TTM Palatin Technologies (PTN) P/E is -3.41. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Palatin Technologies (PTN)

YearP/EChange
2026-3.41-61.81%
2025-8.93N/A

Comparison Palatin Technologies (PTN) P/E with competitors

Palatin Technologies (PTN) P/E is -3.41.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.19%
FGENFibroGen Inc0.24-107.04%
CHRSCoherus Biosciences Inc0.85-124.88%
FBIOFortress Biotech Inc0.95-127.82%
ORMPOramed Pharmaceuticals Inc1.50-144.06%
AGENAgenus Inc3.01-188.23%
INVAInnoviva Inc3.15-192.46%
VXRTVaxart Inc3.55-204.06%
CRMDCorMedix Inc3.63-206.37%
CVACCureVac N.V.4.45-230.33%
GLPGGalapagos NV4.86-242.44%
SRPTSarepta Therapeutics Inc4.88-243.12%
ABEOAbeona Therapeutics Inc5.39-257.94%
ABUSArbutus Biopharma Corp5.60-264.04%
ZVRAZevra Therapeutics Inc5.89-272.59%
SPROSpero Therapeutics Inc6.23-282.59%
CGENCompugen Ltd6.31-285.10%
RIGLRigel Pharmaceuticals6.87-301.46%
SLXNSilexion Therapeutics Corp7.30-313.89%
OMEROmeros Corporation9.26-371.42%
AUPHAurinia Pharmaceuticals Inc9.58-380.99%
PLXProtalix BioTherapeutics Inc10.89-419.28%
ACADAcadia Pharmaceuticals Inc11.73-443.83%
TBPHTheravance Biopharma Inc12.26-459.47%
ADMAAdma Biologics Inc12.42-464.04%
HRMYHarmony Biosciences Holdings Inc13.82-505.15%
SABSSAB Biotherapeutics Inc14.14-514.41%
NAGENiagen Bioscience Inc14.82-534.40%
INCYIncyte Corp15.82-563.85%
REGNRegeneron Pharmaceuticals Inc15.86-564.85%
PBYIPuma Biotechnology Inc17.32-607.62%
CPRXCatalyst Pharmaceuticals Inc17.44-611.24%
EXELExelixis Inc17.54-614.14%
TGTXTG Therapeutics Inc18.97-656.00%
MDXGMimedx Group Inc20.55-702.51%
XOMAXOMA Royalty Corp22.87-770.60%
ARGXArgen X SE24.30-812.33%
CTMXCytomX Therapeutics Inc24.82-827.66%
XOMAOXOMA Royalty Corp25.34-843.02%
HALOHalozyme Therapeutics Inc25.62-851.19%
XOMAPXOMA Royalty Corp25.67-852.55%
VRTXVertex Pharmaceuticals Inc27.99-920.70%
RPRXRoyalty Pharma plc - Class A28.69-941.01%
SLNOSoleno Therapeutics Inc29.02-950.62%
ASNDAscendis Pharma A/S30.09-982.00%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1211.44%
APLSApellis Pharmaceuticals Inc39.02-1243.96%
BMRNBiomarin Pharmaceutical Inc42.21-1337.50%
KRYSKrystal Biotech Inc45.34-1429.31%
ONCBeiGene Ltd69.54-2138.67%
PHARPharming Group N.V.75.03-2299.48%
TECHBio-Techne Corp101.96-3089.05%
VCELVericel Corp109.92-3322.50%
ALNYAlnylam Pharmaceuticals Inc117.96-3558.31%
GMABGenmab140.29-4212.82%
TLXTelix Pharmaceuticals Ltd162.15-4853.73%
CORTCorcept Therapeutics Inc212.86-6340.21%